Table 1.
compound | % cell viabilitya | compound | % cell viabilitya | ||
---|---|---|---|---|---|
HeLa | MCF-7/AZ | HeLa | MCF-7/AZ | ||
6 | 78 ± 3 | 83 ± 5 | 23 | 89 ± 4 | 92 ± 3 |
5 | 70 ± 9 | 82 ± 11 | 27 | 60 ± 3 | 64 ± 6 |
7 | 59 ± 8 | 48 ± 3 | narciclasine | 6 ± 1 | 8 ± 2 |
% cell viability after 48 h of treatment with indicated compounds at 300 μM relative to DMSO control ± SD from two independent experiments, each performed in 8 replicates, determined by MTT assay.